Document Detail


Plasma endothelin-1 levels in patients with biliary atresia: possible role in development of portal hypertension.
MedLine Citation:
PMID:  12748798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Biliary atresia (BA) is a severe neonatal liver disease characterized by progressive extrahepatic biliary tract and intrahepatic inflammatory process. Hepatic fibrosis and portal hypertension (PH) still occur despite the disappearance of jaundice following successful hepatic portoenterostomy. Endothelin-1 (ET-1) is a potent vasoconstrictor and has been reported to stimulate hepatic collagen synthesis. The aim of this study was to demonstrate the potential role of ET-1 in the pathogenesis of the progressive inflammation, fibrosis and PH in BA. METHODS: Thirty pediatric patients with biliary atresia post-hepatic portoenterostomy and 12 healthy children were examined. The ET-1 level was determined by commercially available enzyme-linked immunosorbent assay kits. RESULTS: Endothelin-1 levels were elevated in the patients compared with those of the controls (5.45+/-3.34 vs. 2.74+/-2.17 pg/ml, P = 0.01). Moreover, patients with PH also had greater levels of ET-1 than those without PH (6.73+/-3.27 vs. 3.26+/-2.2 pg/ml, P = 0.004). Patients with abnormal transaminase enzymes had significantly higher ET-1 levels than those with normal enzymes (6.43+/-3.33 vs. 3.17+/-2.1 pg/ml, P = 0.01). In the jaundice-free group, endothelin-1 levels were elevated in the patients with PH compared with those without PH (5.93+/-2.15 vs. 2.88+/-2.1 pg/ml, P = 0.02). CONCLUSIONS: Our findings showed elevation of plasma ET-1 levels in patients with BA, especially in those with PH. ET-1 levels were also higher in patients with elevated transminase enzymes as well as in the jaundice-free group with PH. ET-1 might play a role in the pathogenesis of the progressive inflammation, fibrosis and PH in BA.
Authors:
V Chongsrisawat; P Chatchatee; R Samransamruajkit; P Vanapongtipagorn; P Chottivittayatarakorn; Y Poovorawan
Related Documents :
12010368 - Immunohistochemical localization of cea, ca19-9 and du-pan-2 in hepatitis c virus-infec...
3578508 - Studies of gut and hepatic metabolism in conscious rabbits.
9486048 - Hepatic vein pulsatility assessment on spectral doppler ultrasound.
12629978 - Hepatic encephalopathy secondary to transtumoral portal-hepatic venous shunting.
17052138 - Antiretroviral medication considerations for individuals coinfected with hiv and hepati...
18945778 - Evidence for persistent low-level viremia in individuals who control human immunodefici...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2003-05-13
Journal Detail:
Title:  Pediatric surgery international     Volume:  19     ISSN:  0179-0358     ISO Abbreviation:  Pediatr. Surg. Int.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-08-27     Completed Date:  2004-02-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8609169     Medline TA:  Pediatr Surg Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  478-81     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Faculty of Medicine, Viral Hepatitis Research Unit, Chulalongkorn University and Hospital, 10330 Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biliary Atresia / blood*,  complications
Child
Child, Preschool
Disease Progression
Endothelin-1 / blood*
Female
Fibrosis
Humans
Hypertension, Portal / blood*,  etiology
Infant
Male
Chemical
Reg. No./Substance:
0/Endothelin-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tuberculosis of the gall bladder
Next Document:  Small bowel perforation in the premature neonate: congenital or acquired?